Explore stories from Atlantic Canada.
Islanders flock to Charlottetown Flea Market for affordable finds amid rising costs | SaltWire - Moderna on Thursday reported quarterly revenue that beat Wall Street estimates but came in dramatically lower than the previous year when demand for COVID-19 vaccines was higher.
The drugmaker also posted a smaller-than-expected loss of $3.07 per share. Analysts had expected a quarterly loss of $3.58 a share, according to LSEG data. Analysts on average expect Moderna's COVID shot to bring in $3.73 billion in 2024 and for its RSV vaccine to make $166.67 million. They estimate that the company will generate $4.18 billion in 2024 sales.
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Wind farm developer Orsted confident about strategy after Q1 profit risesExplore stories from Atlantic Canada.
Read more »
Stanley Black and Decker's profit beats on strong industrial tool demandExplore stories from Atlantic Canada.
Read more »
Apollo's Q1 earnings jump 26% on management fees, annuities inflowExplore stories from Atlantic Canada.
Read more »
Court rejects appeal from man sentenced in 2022 Sussex carjackingExplore stories from Atlantic Canada.
Read more »
Saint John councillor Paula Radwan sanctioned for code of conduct breachExplore stories from Atlantic Canada.
Read more »
Taiwan reports second Chinese 'combat patrol' in a weekExplore stories from Atlantic Canada.
Read more »